Network Insights Methodology Get Access

NIH

ORG Government / Medical Research & Public Health Administration Momentum 14.6ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

NIH ($48.5B budget, Bethesda) operates 27 institutes and centers conducting biomedical research across the US federal system. Leadership vacuum widened as 15 of 27 institutes now led by acting directors amid unfilled permanent positions.

-0.80
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
14.6
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
12
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Connected Entities
CDC White House Donald Trump HHS Congress RFK Jr. AMA Senate Supreme Court Mayo Clinic FDA GOP DOJ NEJM AP
Watch This Entity
PSI Intelligence
30-Day Trend
2026-04-28 2026-05-28 12 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.977
Narrative Drift
0.000
Spectral Shift
1184.899
Sentiment-Momentum Divergence
0.000
Source Concentration
0.601
Peer Comparison
Not yet ranked. Sector-relative scoring requires at least four entities in the same BICS sector with PSI history; this entity does not yet meet the threshold or sits in a sector with insufficient peers.
Network Analysis
12 Degree Centrality
Ego Network (top connections)
CDC (weight 11.0)White House (weight 9.0)Donald Trump (weight 9.0)HHS (weight 7.0)Congress (weight 5.0)RFK Jr. (weight 4.0)AMA (weight 4.0)Senate (weight 3.0) CDCWhite HouseDonald TrumpHHSCongressRFK Jr.AMASenate NIH (degree 12) NIH
Centrality History
2026-04-28 2026-05-28 12 0 Degree Mentions
EntityWeight StatusFirst Seen
CDC 11 STABLE
White House 9 STABLE
Donald Trump 9 STABLE
HHS 7 STABLE
Congress 5 STABLE
RFK Jr. 4 NEW
AMA 4 NEW
Senate 3 STABLE
Supreme Court 3 STABLE
Mayo Clinic 2 NEW
FDA 2 STABLE
GOP 2 STABLE
DOJ 2 STABLE
NEJM 1 STABLE
AP 1 STABLE
MP 1 NEW
Harvard Chan 1 NEW
Article Coverage (20)
DateLaneTitle
2026-05-22 Healthcare M&A Retro Biosciences to Reshape Aging Research With 1.8 Billion Valuation
2026-05-22 Healthcare M&A Retro Biosciences to Reshape Aging Research With 1.8 Billion Valuation
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-22 Healthcare Marketing Biotech and Pharma Brace For Continued N.I.H. Funding Cuts in Second Trump Term
2026-04-04 Healthcare Marketing White House Seeks 12% Cut to HHS in 2027
2026-04-04 Healthcare Marketing White House Seeks 12% Cut to HHS in 2027
2026-04-04 Healthcare M&A Advent Partners-Backed Efex Acquires Priority 1 IT
2026-04-04 Healthcare M&A Advent Partners-Backed Efex Acquires Priority 1 IT
2026-04-04 Healthcare M&A Advent Partners-Backed Efex Acquires Priority 1 IT
2026-03-29 Healthcare M&A Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
2026-03-29 Healthcare M&A Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
2026-03-28 Healthcare M&A China's Biotech Boom Is Rewriting Everything
2026-03-28 Healthcare M&A China's Biotech Boom Is Rewriting Everything

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-28 ← Intelligence Network